{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:08:40Z","timestamp":1792199320209,"version":"4.4.0"},"reference-count":30,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T00:00:00Z","timestamp":1560211200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2019,5,8]]},"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1136\/ejhpharm-2019-001903","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T17:25:13Z","timestamp":1560273913000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Adjusting the dose in paediatric care: dispersing four different aspirin tablets and taking a proportion"],"prefix":"10.1136","volume":"28","author":[{"given":"J\u00f8rgen","family":"Brustugun","sequence":"first","affiliation":[{"name":"Oslo Hospital Pharmacy, Hospital Pharmacies Enterprise, South Eastern Norway, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Notaker","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse Holtan","family":"Paetz","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-4183","authenticated-orcid":false,"given":"Ingunn","family":"Tho","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Bjerknes","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy Enterprises Norway, L\u00f8renskog, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,6,11]]},"reference":[{"key":"2025090701215932000_28.2.76.1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1542\/peds.104.S3.607","article-title":"Lack of pediatric drug formulations","volume":"104","author":"Nahata","year":"1999","journal-title":"Pediatrics"},{"key":"2025090701215932000_28.2.76.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.05.006"},{"key":"2025090701215932000_28.2.76.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1768-9"},{"key":"2025090701215932000_28.2.76.4","unstructured":"European Union Paediatric Regulation . Regulation (EC) NO 1901\/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use, OJ L 378, 27.12.2006; 2006."},{"key":"2025090701215932000_28.2.76.5","first-page":"316","article-title":"Unlicensed and off-label drug use in children before and after pediatric governmental initiatives","volume":"20","author":"Corny","year":"2015","journal-title":"J Pediatr Pharmol Ther"},{"key":"2025090701215932000_28.2.76.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1089-1"},{"key":"2025090701215932000_28.2.76.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7227.79"},{"key":"2025090701215932000_28.2.76.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2012.02656.x"},{"key":"2025090701215932000_28.2.76.9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jphp.12581","article-title":"Off-label and unlicensed medicines to hospitalised children in Norway","volume":"69","author":"Teigen","year":"2017","journal-title":"J Pharm Pharmacol"},{"key":"2025090701215932000_28.2.76.10","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2012-000133"},{"key":"2025090701215932000_28.2.76.11","doi-asserted-by":"crossref","unstructured":"Richey RH , Shah UU , Peak M , et al . Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatr 2013;13.doi:10.1186\/1471-2431-13-81","DOI":"10.1186\/1471-2431-13-81"},{"key":"2025090701215932000_28.2.76.12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2016.12.032","article-title":"A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice","volume":"518","author":"Richey","year":"2017","journal-title":"Int J Pharm"},{"key":"2025090701215932000_28.2.76.13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/apa.13700","article-title":"Manipulating tablets and capsules given to hospitalised children in Norway is common practice","volume":"106","author":"Bjerknes","year":"2017","journal-title":"Acta Paediatr"},{"key":"2025090701215932000_28.2.76.14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/ajhp\/61.14.1482","article-title":"Accuracy of splitting unscored valdecoxib tablets","volume":"61","author":"Boggie","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"2025090701215932000_28.2.76.15","first-page":"253","article-title":"Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications","volume":"15","author":"Hill","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"2025090701215932000_28.2.76.16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jvc.2009.04.003","article-title":"Analysis of weight uniformity, content uniformity and 30-day stability in halves and quarters of routinely prescribed cardiovascular medications","volume":"11","author":"Margiocco","year":"2009","journal-title":"J Vet Cardiol"},{"key":"2025090701215932000_28.2.76.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2010.05477.x"},{"key":"2025090701215932000_28.2.76.18","first-page":"76","article-title":"Tablet splitting: is it worthwhile? Analysis of drug content and weight uniformity for half tablets of 16 commonly used medications in the outpatient setting","volume":"21","author":"Helmy","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"2025090701215932000_28.2.76.19","unstructured":"MODRIC \u2013 Manipulation of Drugs Required in Children. A guideline for health professionals. Alder Hey Children\u2019s NHS Foundation Trust, UK, 2017. Available: http:\/\/www.alderhey.nhs.uk\/wp-content\/uploads\/MODRIC-GUIDELINES-April-2017.pdf [Accessed 27 Feb 2018]."},{"key":"2025090701215932000_28.2.76.20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0974-2069.107236","article-title":"Anti-platelet agents in pediatric cardiac practice","volume":"6","author":"Mohanty","year":"2013","journal-title":"Ann Pediatr Cardiol"},{"key":"2025090701215932000_28.2.76.21","unstructured":"BNF for Children . Aspirin (acetylsalicylic acid). Available: https:\/\/www.medicinescomplete.com\/ [Accessed 28 Nov 2018]."},{"key":"2025090701215932000_28.2.76.22","first-page":"27","article-title":"Dose uniformity of samples prepared from dispersible aspirin tablets for paediatric use","volume":"14","author":"Broadhurst","year":"2008","journal-title":"Eur J Hospital Pharm Sci"},{"key":"2025090701215932000_28.2.76.23","unstructured":"O\u2019Neal MJ , Smith A , Heckelman PE , eds. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th ed. Aspirin. Whitehouse Station, NJ: Merck & Co., inc, 2001."},{"key":"2025090701215932000_28.2.76.24","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600590523"},{"key":"2025090701215932000_28.2.76.25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2018.04.054","article-title":"How close is the dose? Manipulation of 10\u202fmg hydrocortisone tablets to provide appropriate doses to children","volume":"545","author":"Watson","year":"2018","journal-title":"Int J Pharm"},{"key":"2025090701215932000_28.2.76.26","unstructured":"European Pharmacopoeia . Tablets, Compressi. 01\/2018:0478. Available: http:\/\/online.edqm.eu\/ [Accessed 16 Apr 2019]."},{"key":"2025090701215932000_28.2.76.27","unstructured":"European Pharmacopoeia . General notices. 07\/2014:10000, corr 9.2. Available: http:\/\/online.edqm.eu\/ [Accessed 31 Mar 2019]."},{"key":"2025090701215932000_28.2.76.28","unstructured":"European Pharmacopoeia . Recommendations on dissolution testing. 07\/2010:51701. Available: http:\/\/online.edqm.eu\/ [Accessed 1 May 2019]."},{"key":"2025090701215932000_28.2.76.29","doi-asserted-by":"publisher","DOI":"10.1111\/apa.12291"},{"key":"2025090701215932000_28.2.76.30","unstructured":"EMA . EMA\/CHMP\/QWP\/805880\/2012 rev. 2. Guideline on pharmaceutical development of medicines for paediatric use 2013."}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2019-001903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T08:22:13Z","timestamp":1757233333000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2019-001903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,11]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,19]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1136\/ejhpharm-2019-001903"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2019-001903","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,11]]}}}